Royalty Pharma is a private equity firm and venture debt provider. Based in New York, United States. Known portfolio companies include Zenas BioPharma, Zymeworks, Revolution Medicines, Elektrofi, Kailera Therapeutics and Syndax Pharmaceuticals, 10 companies in all.
Is Royalty Pharma a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Who to pitch at Royalty Pharma
Royalty Pharma portfolio companies (10)
- Zenas BioPharma
- Zymeworks
- Revolution Medicines
- Elektrofi
- Kailera Therapeutics
- Syndax Pharmaceuticals
- Cytokinetics
- Denali Therapeutics
- Teva Pharmaceuticals
- Ascendis Pharma
Co-investors
Funds that share portfolio companies with Royalty Pharma.
Similar funds
Showing 20 of 100
About Royalty Pharma
The firm's listing covers sector Healthcare, and focus areas Biotech, Pharma and Pharma Royalties; known deals cluster at Growth, Late-Stage and Series B.
The team counts 5 people in our database. Pablo Legorreta (Founder & Chief Executive Officer) and Sam Glazer (Senior Associate, Research & Investments) are shown as the contacts to pitch.
Across the known portfolio, 20 co-investors appear alongside Royalty Pharma, including Teralys Capital, Enavate Sciences and Sirona Capital.
Frequently asked questions
What is Royalty Pharma?
Royalty Pharma is a private equity firm and venture debt provider based in New York, United States, with a known portfolio of 10 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Royalty Pharma invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Pharma and Pharma Royalties. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Royalty Pharma invest at?
The known deals of Royalty Pharma include Growth, Late-Stage and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Royalty Pharma?
2 of the 5 people on file at Royalty Pharma are listed as contacts for the firm. All 5 have their own profile page.
How do I contact Royalty Pharma?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 5 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal